Opportunity Information: Apply for CDC RFA GH13 134405CONT18
The grant opportunity titled "HIV Coinfection Surveillance Strategies for Program Planning in Central America and Panama Region in Guatemala" is a continuation funding notice issued by the U.S. Centers for Disease Control and Prevention (CDC), specifically under its Center for Global Health (CGH). It is structured as a cooperative agreement, which means the CDC is expected to have substantial involvement in the work beyond simply providing funds. The focus is in the health category and centers on strengthening HIV coinfection surveillance so that national and regional programs can make better, data-driven planning decisions for Guatemala and the broader Central America and Panama region.
This particular notice is not an open competition. It is explicitly limited to continuation funding for organizations that were already funded under the earlier opportunity CDC-RFA-GH13-1344, using the continuation identifier CDC RFA GH13 134405CONT18. In practice, that means only the existing grantees from the prior award are eligible to receive these continuation funds, and new applicants should not expect to be considered. The eligible applicant category is listed as "Others," but the narrative restriction makes clear that eligibility is effectively confined to prior awardees under the referenced funding announcement.
The primary purpose of the award is to sustain and build upon ongoing surveillance activities related to HIV coinfections, which commonly include conditions such as tuberculosis, viral hepatitis, and sexually transmitted infections that can complicate HIV treatment and outcomes. By supporting surveillance strategies, the project aims to improve the quality, consistency, and usefulness of data collected through public health systems. This type of work often involves strengthening routine reporting, improving case detection and diagnostic confirmation, supporting laboratory and information systems, integrating data streams across programs, and ensuring that surveillance outputs translate into actionable program planning and resource allocation.
Key administrative details from the source information include a creation date of August 30, 2017, and an original closing date of November 30, 2017. The funding instrument is a cooperative agreement, and the CFDA number associated with the opportunity is 93.067, which corresponds to CDC global health assistance activities. The record lists an award ceiling of 0 and does not specify the expected number of awards, which is common in continuation notices where funding levels and award counts are determined based on existing agreements, available appropriations, and satisfactory progress under the prior project period rather than through a new competitive selection.
Overall, the opportunity is best understood as a mechanism for the CDC to continue supporting established partners already working on HIV coinfection surveillance in Guatemala and the surrounding region, with the goal of ensuring that surveillance systems remain strong, that data are reliable and timely, and that ministries of health and implementing partners can use those findings to plan interventions, target high-burden populations, and monitor the impact of HIV and related coinfections on public health.Apply for CDC RFA GH13 134405CONT18
- The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "HIV Coinfection Surveillance Strategies for Program Planning in Central America and Panama Region in Guatemala" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on 2017-08-30.
- Applicants must submit their applications by 2017-11-30. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "HIV Coinfection Surveillance Strategies for Program Planning in Central America and Panama Region in Guatemala."
Which U.S. agency is offering this funding?
The funding notice is issued by the U.S. Centers for Disease Control and Prevention (CDC), under its Center for Global Health (CGH).
What type of funding instrument is this?
This opportunity is structured as a cooperative agreement. That means CDC is expected to have substantial involvement in the work beyond simply providing funds.
Is this an open, competitive grant opportunity?
No. This notice is explicitly not an open competition. It is a continuation funding notice.
Who is eligible to receive this continuation funding?
Eligibility is effectively limited to organizations that were already funded under the earlier opportunity CDC-RFA-GH13-1344. New applicants should not expect to be considered.
What continuation identifier is associated with this notice?
The continuation identifier listed is CDC RFA GH13 134405CONT18.
What is the main purpose of this continuation award?
The primary purpose is to sustain and build upon ongoing surveillance activities related to HIV coinfections, so national and regional programs can make better, data-driven planning decisions for Guatemala and the broader Central America and Panama region.
What health area does this opportunity focus on?
It is in the health category and centers on strengthening HIV coinfection surveillance for program planning.
What geographic area is emphasized in the opportunity?
The work is focused on Guatemala and the broader Central America and Panama region.
What does "HIV coinfection surveillance" mean in the context of this notice?
In this context, it refers to improving systems that track and report conditions that occur alongside HIV and can affect outcomes, with the goal of producing reliable, timely data that can be used for planning and resource allocation.
Which coinfections are commonly included in the surveillance focus described?
The notice describes coinfections that commonly include tuberculosis, viral hepatitis, and sexually transmitted infections, which can complicate HIV treatment and outcomes.
What kinds of activities are typically involved in strengthening surveillance strategies under this project?
The description indicates this type of work often involves strengthening routine reporting, improving case detection and diagnostic confirmation, supporting laboratory and information systems, integrating data streams across programs, and ensuring surveillance outputs translate into actionable program planning and resource allocation.
How are the surveillance outputs expected to be used?
The intent is for ministries of health and implementing partners to use the surveillance findings to plan interventions, target high-burden populations, and monitor the impact of HIV and related coinfections on public health.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.067, corresponding to CDC global health assistance activities.
What are the key dates listed for this funding notice?
The creation date is August 30, 2017, and the original closing date is November 30, 2017.
Is an award amount (ceiling) provided in the record?
The record lists an award ceiling of 0.
Does the notice specify the expected number of awards?
No. The expected number of awards is not specified.
Why might a continuation notice list an award ceiling of 0 or omit the expected number of awards?
Based on the description provided, this is common in continuation notices where funding levels and award counts are determined based on existing agreements, available appropriations, and satisfactory progress under the prior project period, rather than through a new competitive selection.
What does the eligible applicant category "Others" mean here?
Although the eligible applicant category is listed as "Others," the narrative restriction makes clear that eligibility is effectively confined to prior awardees under the referenced funding announcement.
What is the overall goal of continuing this funding?
Overall, the goal is to continue supporting established partners already working on HIV coinfection surveillance so surveillance systems remain strong, data are reliable and timely, and programs can use findings for planning and monitoring.
Browse more opportunities from the same category: Health
Next opportunity: Comparative Genomics Research Program (R01)
Previous opportunity: NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention Infrastructure Resource Access (X01)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 134405CONT18
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 134405CONT18) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening Clinical Services of PLHIV in Central America under PEPFAR Apply for CDC RFA GH17 177602CONT18 Funding Number: CDC RFA GH17 177602CONT18 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Building Capacity along the Continuum from Prevention to Care and Treatment for Key Populations in the Central America Region under PEPFAR Apply for CDC RFA GH15 151004CONT18 Funding Number: CDC RFA GH15 151004CONT18 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Establishment of a Strategic Partnership to Strengthen the COMISCA under PEPFAR Apply for CDC RFA GH15 150904CONT18 Funding Number: CDC RFA GH15 150904CONT18 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01) Apply for PAR 17 466 Funding Number: PAR 17 466 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21) Apply for PAR 17 463 Funding Number: PAR 17 463 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low and Middle- Income Countries (R21) Apply for PAR 17 474 Funding Number: PAR 17 474 Agency: National Institutes of Health Category: Health Funding Amount: $125,000 |
| NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44) Apply for PAR 17 480 Funding Number: PAR 17 480 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44) Apply for PAR 17 479 Funding Number: PAR 17 479 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Repurposing Target-Based Pharmaceutical Libraries for Discovery of Therapeutics against Eukaryotic Pathogens (R21/R33) Apply for RFA AI 17 036 Funding Number: RFA AI 17 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Next Generation Multipurpose Prevention Technologies (NGM) (R61/R33 Clinical Trial Optional) Apply for RFA AI 17 028 Funding Number: RFA AI 17 028 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Agency for Healthcare Research and Quality (AHRQ)-sponsored National Research Service Award (NRSA)Individual Postdoctoral Fellowship (F32) Apply for PA 17 481 Funding Number: PA 17 481 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Comparative Genomics Research Program (R01) Apply for PAR 17 482 Funding Number: PAR 17 482 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improved Quality and Sustainability of Medication Assisted Treatment in Ukraine under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 159403CONT18 Funding Number: CDC RFA GH15 159403CONT18 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| NIMH Research Education Mentoring Programs for HIV/AIDS Researchers (R25) Apply for PAR 17 485 Funding Number: PAR 17 485 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Accessible Continuum of Care and Essential Services Sustained (ACCESS) Apply for RFI 687 17 002 Funding Number: RFI 687 17 002 Agency: Madagascar USAID-Antananarivo Category: Health Funding Amount: $85,000,000 |
| Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (R34) Apply for RFA RM 17 024 Funding Number: RFA RM 17 024 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (U01) Apply for RFA RM 17 023 Funding Number: RFA RM 17 023 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NIH Science Education Partnership Award (SEPA) (R25) Apply for PAR 17 339 Funding Number: PAR 17 339 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Collaborative Centers (U54) Apply for RFA RM 17 020 Funding Number: RFA RM 17 020 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Science of Behavior Change: Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (R21) Apply for RFA RM 17 028 Funding Number: RFA RM 17 028 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 134405CONT18", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.